NEW YORK (GenomeWeb News) - Roche Diagnostics has licensed its Melting Curve Analysis technology to Eppendorf, the companies said Tuesday.
The non-exclusive agreement allows Eppendorf to develop and commercialize products based on the technology, which is a technique for analyzing PCR products. The deal does not allow Eppendorf to use the IP in human and veterinary in vitro diagnostics.
The Melting Curve Analysis technology identifies DNA and is used after PCR. It involves heating the PCR product slowly until each double-stranded DNA rises to its unique melting temperature.
Financial terms of the agreement were not disclosed.